| (in millions of euros) | December 31, 2024 | December 31, 2023 |
|---|---|---|
| Other financial assets at fair value through profit and loss: | Other financial assets at fair value through profit and loss: December 31, 2024
|
Other financial assets at fair value through profit and loss: December 31, 2023
|
|
Venture Capital Funds (1) |
Venture Capital Funds (1) December 31, 2024112 |
Venture Capital Funds (1) December 31, 2023144 |
|
Other |
Other December 31, 202423 |
Other December 31, 202319 |
| Security deposits (2) | Security deposits (2)December 31, 202443 |
Security deposits (2)December 31, 202343 |
| Loans to equity-accounted investees and non-consolidated companies | Loans to equity-accounted investees and non-consolidatedcompanies December 31, 202439 |
Loans to equity-accounted investees and non-consolidatedcompanies December 31, 202337 |
| Sub-lease receivables (3) | Sub-lease receivables (3)December 31, 202439 |
Sub-lease receivables (3)December 31, 202343 |
| Surplus of plan assets for pension commitments (4) | Surplus of plan assets for pension commitments (4)December 31, 202431 |
Surplus of plan assets for pension commitments (4)December 31, 202335 |
| Other | Other December 31, 202430 |
Other December 31, 202322 |
| Gross value | Gross valueDecember 31, 2024317 | Gross valueDecember 31, 2023343 |
| Impairment | Impairment December 31, 2024(30) |
Impairment December 31, 2023(27) |
| Net amount | Net amount December 31, 2024287 |
Net amount December 31, 2023316 |
| (in millions of euros) | December 31, 2024 | December 31, 2023 |
|---|---|---|
| Inventories | Inventories December 31, 2024186 |
Inventories December 31, 2023153 |
| Work-in-progress | Work-in-progress December 31, 2024193 |
Work-in-progress December 31, 2023211 |
| Gross value | Gross valueDecember 31, 2024379 | Gross valueDecember 31, 2023364 |
| Impairment of inventories and work-in-progress | Impairment of inventories and work-in-progress December 31, 2024(18) |
Impairment of inventories and work-in-progress December 31, 2023(23) |
| Net amount | Net amount December 31, 2024361 |
Net amount December 31, 2023341 |
| (in millions of euros) | December 31, 2024 | December 31, 2023 |
|---|---|---|
| Trade receivables(1) | Trade receivables (1)December 31, 2024 15,755 |
Trade receivables (1)December 31, 2023 13,583 |
| Notes receivable | Notes receivable December 31, 2024 8 |
Notes receivable December 31, 2023 2 |
| Gross value | Gross value December 31, 2024 15,763 |
Gross value December 31, 2023 13,585 |
| Opening impairment | Opening impairment December 31, 2024 (185) |
Opening impairment December 31, 2023 (183) |
| Impairment over the year | Impairment over the year December 31, 2024 (23) |
Impairment over the year December 31, 2023 (41) |
| Reversals during the year | Reversals during the year December 31, 2024 45 |
Reversals during the year December 31, 2023 36 |
| Change in scope | Change in scope December 31, 2024 (2) |
Change in scope December 31, 2023 - |
| Foreign exchange and others | Foreign exchange and others December 31, 2024 (3) |
Foreign exchange and others December 31, 2023 3 |
| Closing impairment | Closing impairment December 31, 2024 (168) |
Closing impairment December 31, 2023 (185) |
| Net amount | Net amount December 31, 2024 15,595 |
Net amount December 31, 2023 13,400 |
